LIQUIDIA CORPORATION -

Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of Administration

24 مايو 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Liquidia Reports First Quarter 2021 Financial Results and Provides Corporate Update

13 مايو 2021 06:00:01 بحسب Nasdaq GlobeNewswire

Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension

10 مايو 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Liquidia Corporation to Report First Quarter 2021 Financial Results on May 13, 2021

06 مايو 2021 06:00:01 بحسب Nasdaq GlobeNewswire

Liquidia Corporation Announces $21.7 Million Private Placement

13 أبريل 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Liquidia Corporation To Present At The 20th Annual Needham Virtual Healthcare Conference

07 أبريل 2021 06:00:01 بحسب Nasdaq GlobeNewswire

Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of Administration

30 مارس 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Liquidia Corporation Reports Full-Year 2020 Financial Results and Provides Corporate Update

23 مارس 2021 06:00:01 بحسب Nasdaq GlobeNewswire

Liquidia Corporation to Host 2020 Financial Results Conference Call on March 23, 2021

09 مارس 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Liquidia Corporation Secures $20.5 Million Debt Facility with Silicon Valley Bank

02 مارس 2021 07:30:01 بحسب Nasdaq GlobeNewswire